R. Flener
Impact in
- Genetics top 10%
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Chronic Lymphocytic Leukemia Research
- Hematology top 10%
- Acute Myeloid Leukemia Research
- Multiple Myeloma Research and Treatments
Papers in
- Genetics 12
- Chronic Lymphocytic Leukemia Research 8
- Myeloproliferative Neoplasms: Diagnosis and Treatment 4
- Immunology 11
- Immune Cell Function and Interaction 7
- Immunodeficiency and Autoimmune Disorders 3
- Co-authors
- Günther Gastl (10 shared papers)Jakob Troppmair (6 shared papers)Herbert Tilg (6 shared papers)Walter E. Aulitzky (6 shared papers)Heinz Ludwig (6 shared papers)Manfred Herold (3 shared papers)Werner Linkesch (4 shared papers)C. Huber (6 shared papers)
In The Last Decade
R. Flener
27 papers receiving 367 citations
Peers
Comparison fields: 5 of 67
- Genetics 107
- Hematology 97
- Immunology 119
- Rheumatology 62
- Clinical Biochemistry 25
Countries citing papers authored by R. Flener
This map shows the geographic impact of R. Flener's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Flener with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Flener more than expected).
Fields of papers citing papers by R. Flener
This network shows the impact of papers produced by R. Flener. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Flener. The network helps show where R. Flener may publish in the future.
Co-authors
The 25 scholars most cited alongside R. Flener, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | In-vitro and in-vivo studies on the induction of neopterin biosynthesis by cytokines, alloantigens and lipopolysaccharide (LPS). | 1988 | 73 |
| 2 | 1987 | 42 | |
| 3 | 1986 | 39 | |
| 4 | Effects of human recombinant alpha 2 arg-interferon and gamma-interferon on human breast cancer cell lines: dissociation of antiproliferative activity and induction of HLA-DR antigen expression. | 1985 | 37 |
| 5 | 1986 | 25 | |
| 6 | 1987 | 24 | |
| 7 | 1986 | 19 | |
| 8 | 1988 | 18 | |
| 9 | 1991 | 18 | |
| 10 | [Therapy with interferon (recombinant IFN-alpha-2C) in myeloproliferative diseases with severe thrombocytoses]. | 1985 | 16 |
| 11 | 1986 | 15 | |
| 12 | 1988 | 12 | |
| 13 | Phase I study of recombinant human tumor necrosis factor-alpha in patients with advanced malignancies. | 1988 | 8 |
| 14 | 1989 | 6 | |
| 15 | Anxiolytics and beta blockers: evaluation of pharmacodynamics by quantitative EEG, psychometric and physiological variables. | 1981 | 6 |
| 16 | 2009 | 5 | |
| 17 | Determination of psychoactivity and cerebral bioavailability of danitracene (WA 335) by quantitative pharmaco-EEG and psychometric investigations. | 1976 | 4 |
| 18 | [Interferon/Controlled study in 3-year survival of patients with osteosarcoma (author's transl)]. | 1982 | 3 |
| 19 | 2009 | 2 | |
| 20 | Phase II trial of recombinant interferon alpha-2C in metastatic renal cell carcinoma. | 1988 | 2 |
About R. Flener
R. Flener is a scholar working on Genetics, Immunology, Oncology, Hematology and Molecular Biology, having authored 30 papers that have together received 384 indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (8 papers), Immune Cell Function and Interaction (7 papers), Multiple Myeloma Research and Treatments (5 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers), Lymphoma Diagnosis and Treatment (4 papers), Immunodeficiency and Autoimmune Disorders (3 papers), Cytokine Signaling Pathways and Interactions (3 papers) and Renal cell carcinoma treatment (2 papers). The work is most often cited by research in Genetics (107 citations), Hematology (97 citations), Immunology (119 citations), Rheumatology (62 citations) and Clinical Biochemistry (25 citations). R. Flener has collaborated with scholars based in Austria, Belgium and Germany. Frequent co-authors include Günther Gastl, Jakob Troppmair, Herbert Tilg, Walter E. Aulitzky, Heinz Ludwig, Manfred Herold, Werner Linkesch, C. Huber, Heinz Gisslinger and W. Aulitzky. Their work appears in journals such as Oncology, Immunobiology, Annals of Hematology, Transplantation and The Journal of Urology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.